This site uses cookies to bring you the best experience. Find out more
Skip to main content

SECURITIES INFORMATION

 

NUMBER OF AIM SECURITIES IN ISSUE

As of 30 September 2022, the number of shares in issue was 380,858,607.

SIGNIFICANT SHAREHOLDERS

As of 30 September 2022, significant shareholdings in the share capital of Eden Research plc were:

Name

Number of shares

% of the issued ordinary share capital

BGF Investment Management Limited

 

53,733,000

14.11%

Sipcam Oxon S.p.A.

 

37,614,830

9.88%

Hargreaves Lansdown

 

29,839,285

7.83%

Gresham House Asset Management Limited

 

27,845,445

7.31%
 

Canaccord Genuity Group Inc

 

22,584,000

5.93%

Interactive Investor

 

20,027,730

5.26%

JM Finn Nominees Limited

 

19,277,362

5.06%

Atul Unadkat

 

17,545,098

4.61%

Rathbone Nominees Limited

 

15,708,999

4.12%

HSBC Global Custody Nominee (UK) Limited

 

13,270,588

3.48%

 

Name

Number of shares

% of the issued ordinary share capital

A Abrey                                                                 

 

1,620,346

0.43%

L van der Broek

 

929,500

0.24%

S Smith

 

911,039

0.24%

R Cridland

 

130,167

0.03%

 

SHARES NOT IN PUBLIC HANDS

In the terms of AIM Rules published July 2016 and insofar as it is aware, at 30 September 2022, 31.30% of the Company's AIM securities was not in public hands.

RESTRICTION IN TRANSFER OF AIM SECURITIES

There are no restrictions on the transfer of Eden Research Plc's AIM securities.

DETAILS OF ANY OTHER EXCHANGES AND TRADING PLATFORMS

Eden Research Plc has not applied or agreed to have any of it securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.

UK CITY CODE ON TAKEOVERS AND MERGERS

As an AIM traded UK registered company, Eden Research plc is subject to the UK City Code on Takeovers and Mergers legislation.